Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Cancer Med. 2019 Jul;8(7):3411-3419. doi: 10.1002/cam4.2234. Epub 2019 May 10.
To evaluate the effect of the varied histological subtypes on clinical outcomes and to determine the prognostic implications of mucinous adenocarcinomas (MAC) and signet ring cell carcinomas (SRCC) compared with classic adenocarcinomas (AC).
A total of 8005 patients, including 7502 AC, 428 MAC and 75 SRCC, who underwent definitive surgery between 2007 and 2015 at Fudan University Shanghai Cancer Center were remained for analysis in this study.
MAC and SRCC were more common in right-sided colon cancer, in males and in young patients, compared to AC; moreover, MAC and SRCC led to a higher probability to develop lymph node metastasis, lymphovascular invasion and perineural invasion. For survival outcomes, we found that the 5-year overall survival (OS) of SRCC was significantly lower than that of MAC and AC, while the 5-year OS of MAC is much lower than that of AC. However, in multivariable analysis, the difference in survival between SRCC, MAC and AC was no longer significant, especially when stratified by N stage.
MAC and SRCC are rare subtypes of colorectal cancer with a higher T stage, N stage as well as higher incidence of lymphovascular and nerve invasion. However, neither MAC nor SRCC was an independent predictor of decreased survival in multivariate analysis.
评估不同组织学亚型对临床结局的影响,并比较黏液性腺癌(MAC)和印戒细胞癌(SRCC)与经典腺癌(AC)的预后意义。
本研究纳入了 2007 年至 2015 年在复旦大学附属肿瘤医院接受根治性手术的 8005 例患者,包括 7502 例 AC、428 例 MAC 和 75 例 SRCC。
与 AC 相比,MAC 和 SRCC 更常见于右半结肠癌、男性和年轻患者,且更易发生淋巴结转移、脉管侵犯和神经侵犯。在生存结果方面,我们发现 SRCC 的 5 年总生存率(OS)明显低于 MAC 和 AC,而 MAC 的 5 年 OS 明显低于 AC。然而,在多变量分析中,SRCC、MAC 和 AC 之间的生存差异不再显著,特别是在 N 分期分层后。
MAC 和 SRCC 是结直肠癌的罕见亚型,具有更高的 T 分期、N 分期以及更高的脉管和神经侵犯发生率。然而,在多变量分析中,MAC 和 SRCC 均不是降低生存的独立预测因素。